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Objective: Cardiac surgery with cardiopulmonary bypass is associated with aberrant
neutrophil activation and potentially severe pathogenic sequelae. This experimental
study was done to evaluate a leukocyte inhibition module that rapidly inactivates
neutrophils through CD95 stimulation.
Methods: German landrace pigs (4 groups, each n  5) underwent cardiac surgery
without cardiopulmonary bypass (group I), with cardiopulmonary bypass (group II),
with cardiopulmonary bypass plus a leukocyte filter (group III), and with cardio-
pulmonary bypass plus a leukocyte inhibition module (group IV). The leukocyte
filter or leukocyte inhibition module was introduced into the arterial line of the
heart-lung machine.
Results: Leukocyte counts were decreased by up to 43% in group IV compared with
values in group II (P  .023). In group IV, but not in groups I to III, no delay in
spontaneous neutrophil apoptosis was observed after annexin V–propidium iodide
staining. Late apoptotic (11.7%) or necrotic neutrophils (9.3%) were detected in 2
animals (group IV). Tumor necrosis factor  serum levels increased over time in
groups I to III (2-fold) but remained at baseline levels in group IV (P  .05).
Interleukin 8–mediated chemotactic neutrophil transmigration activity increased
over time in groups I to III but was totally abrogated in group IV at any time point.
The perioperative increase of creatine kinase and creatine kinase MB levels was
lower in groups III (1.5-fold and 1.3-fold, respectively) and IV (1.2-fold and
1.5-fold, respectively) compared with values in group II (both 1.9-fold).
Conclusions: The leukocyte inhibition module downregulated cardiopulmonary
bypass–related neutrophil activity and thus might be beneficial in cardiac surgery
and other clinical settings with unappreciated neutrophil activation.
Cardiac surgery with cardiopulmonary bypass (CPB) is associatedwith a broad array of disorders. One major contributing pathogenicmechanism is the aberrant activation of the immune system elicitedby the contact of patient blood with artificial surfaces of theextracorporeal circuits.1,2 Activated neutrophils are known to elicitendothelial dysfunction through secretion of proteolytic enzymes,
such as elastase or oxygen radicals, followed by edema and tissue destruction.3,4
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In the past, several efforts have been undertaken to limit
neutrophil activity in cardiac surgery through pharmacolog-
ic,5 immunologic,6 and mechanical7 approaches. However,
these attempts resulted in many publications with contra-
dictory results and limited success. Leukocyte filtration has
been adapted from the transfusion services to reduce the
absolute numbers of activated neutrophils.8 However, this
strategy does not necessarily affect the pathogenic activity
of the neutrophils. Recently, our own clinical studies with
leukocyte filters (LFs) focused on the efficacy to impair the
functional neutrophil activity, such as phagocytic activity,
oxidative burst, and elastase levels in the blood. In these
trials with high-risk patients, no significant impairment of
functional neutrophil activity was found, and a clinical
benefit was missing.9 Moreover, levels of polymorphonu-
clear elastase (PMNE), a marker for activated neutrophils,
were significantly increased in the filter group versus CPB
alone, suggesting that mechanical stress and the contact
with the artificial surface within the filter might stimulate
the trapped neutrophils. It is likely that these activated
neutrophils are washed out of the filter and circulate in the
blood stream. Subsequently, neutrophils might attach to the
endothelial wall and transmigrate into subcellular spaces, in
which PMNE might disrupt the extracellular matrix and the
endothelial integrity.
Recently, we showed in vitro that neutrophils binding to
the membrane-bound cell-surface protein Fas ligand (FasL;
CD95L, APO-1L) on retinal epithelial cells detached within
minutes and lost the ability to adhere and transmigrate.10
Interestingly, this loss of neutrophil function occurred inde-
pendently of neutrophil apoptosis. FasL belongs to the tu-
mor necrosis factor (TNF) family and associates with its
receptor Fas (CD95, APO-1). The Fas/FasL system is
known as one of the major apoptosis-inducing pathways and
a key regulator in natural innate immunity.11 However, we
found that Fas-mediated leukocyte inhibition preceded early
signs of apoptosis.
From these findings, we speculated that the stimulation
of Fas on activated neutrophils might be an effective tool to
prevent unwanted leukocyte activity and tissue damage in
the clinical setting of cardiac surgery with CPB. Therefore
we developed a leukocyte inhibition module (LIM) that can
be located within the arterial line of the heart-lung machine.
The LIM does not retain leukocytes but modifies their
function by means of a transient contact with the immune-
modulating biomembrane inside.
Here we report our data on the in vivo evaluation of the
LIM in a porcine model for cardiac surgery and CPB.
Materials and Methods
Porcine Model and CPB
The investigation conforms with the “Guide for the Care and Use
of Laboratory Animals” published by the US National Institutes of
Health (publication no. 85-23, revised 1996). Pigs (German land-
race, 50 kg) were allocated to 4 groups (each n 5). All pigs were
sham operated (median sternotomy) without (group I) or with
(groups II-IV) CPB. Anesthesia was maintained consistently with
sufentanyl, pancuronium, or propofol. Ventilation was performed
with an O2/N2O mixture establishing a fraction of inspired oxygen
of 0.5 and a PCO2 of 35 to 40 mm Hg. After anticoagulation by
means of systemic administration of 300 IU/kg heparin (Liquemin;
Roche, Grenzach-Wyhlen, Germany), CPB (crossclamp time, 60
minutes; reperfusion, 30 minutes) was instituted with a Quadrox
capillary membrane oxygenator and tubing set, including an arte-
rial filter (Pall, 40 m, Dreieich, Germany; group II), an LF (Pall,
LG6, group III), or the LIM (LeukoCare, Munich, Germany; group
IV). The LIM consists of a thermoplastic module with a volume of
200 mL housing a Fas (CD95/APO-1)–inducing polyester-based
fiber with specific 3-dimensional characteristics that allow blood
flow of between 1 and 6 L/min and has rheologic features analo-
gous to standard LFs. The 3-dimensional polyester network carries
an immobilized immunoglobulin M anti-Fas antibody (clone
CH11; Coulter-Immunotech, Hamburg, Germany) and has a sur-
face of greater than 1 m2. The circuit was primed with 1500 mL of
Ringer’s lactate, 500 mL of 6% hydroxyethyl starch, 100 mL of
20% mannitol, and 150 U/kg heparin by using a prebypass filter
(Pall, 0.2 m). Additional heparin was administered when the
activated clotting time decreased to less than 400 seconds. A flow
of 2.4 L · min1 · m2 body surface was applied. The left ventricle
was vented through the cardioplegic needle in the ascending aorta.
Heparin was fully antagonized with protamine sulfate at the end of
CPB. Antegrade cold blood cardioplegia was used (arresting dose,
1000 mL) and reinfused (400 mL) every 20 minutes.
The operation was terminated by means of controlled potas-
sium infusion.
Blood Sampling
Blood samples were obtained immediately before the onset of CPB
(time point A), 5 minutes before the opening of the aortic cross-
clamp (time point B), 15 minutes after the opening of the aortic
crossclamp (time point C), and 10 minutes after weaning from
CPB (time point D).
Isolation of Porcine Polymorphonuclear Leukocytes
The following protocol was used to study whether the LIM might
inhibit the assumed pathogenic mechanisms of neutrophils. A
volume of 25 mL of platelet-poor plasma was obtained by centri-
fuging 50 mL of heparinized blood at 2500g for 10 minutes twice.
The plasma was diluted in Hanks buffer (Gibco, Karlsruhe, Ger-
many) solution to reach a concentration of 10% and used as diluent
or washing solution for further procedures.
Twenty milliliters of heparinized whole blood was diluted with
40 mL of plasma/Hank’s buffer solution, carefully layered on top
of a 59% isotonic Percoll (Biochrom, Berlin, Germany) column,
and centrifuged at 400g for 20 minutes to isolate polymorphonu-
clear leukocytes (PMNs). The pellet containing red blood cells and
PMNs was resuspended (1:2 vol/vol) in 2.5% gelatin containing
Hanks buffer (without plasma) and incubated at 37°C for 50
minutes. The supernatant was collected and centrifuged at 300g for
10 minutes. The remaining red cell pellet was then removed by
means of hypotonic hemolysis with 2 mL of aqua dest (Braun,
Melsungen, Germany). PMNs were harvested and washed twice
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with Hank’s buffer (without plasma) by centrifuging at 300g for 5
minutes. PMN viability was always greater than 95%, as deter-
mined by using Trypan blue exclusion.
Leukocyte Counts
Blood gas and leukocyte counts were routinely determined with a
blood gas analyzer, Cell-Dyn 3500R (Abbott, Wiesbaden Ger-
many).
Enzyme-Linked Immunosorbent Assay
Serum samples were obtained from porcine blood at time points A
through D and stored at 20°C. Commercial enzyme-linked im-
munosorbent assays (ELISAs) were used to determine serum lev-
els of TNF- (Becton Dickinson, Heidelberg, Germany), creatine
kinase (CK), and CK-MB (Roche).
Chemotaxis
Neutrophils were seeded at a concentration of 1  106/mL onto
6.5-mm-diameter transwell filters (Corning and Costar, Mainz,
Germany) with a pore size of 3 m. Cell culture medium in the
lower chamber was supplemented with 500 ng/mL interleukin (IL)
8. After 60 minutes, transwell filters were removed, and neutro-
phils in the lower chamber were counted microscopically. The
amount of transmigrated neutrophils is a measure for the func-
tional activity.
Apoptosis
Neutrophil apoptosis was determined by using the Apoptosis De-
tection Kit (R&D, Wiesbaden, Germany). The principle of this kit
is the ability of living cells to expel propidium iodide (PI) and the
inability to bind annexin V. Neutrophils were isolated from hep-
arinized blood as described above and incubated (0.5  106/mL)
with 0.25 g/mL fluorescein isothiocyanate (FITC)–conjugated
annexin V and 10 L of PI and analyzed by means of flow
cytometry (FACscan, Becton Dickinson). Three subpopulations
were identified: viable cells (FITC/PI), apoptotic cells (FITC/
PI), and necrotic cells (FITC/PI).
Statistical Analysis
Data are shown as mean values SD. Repeated-measures analysis
of variance (MANOVA) and the Fisher exact test were used for
determination of significant differences between groups.
Results
Microscopic evaluation of the LIM polyester fibers after the
end of the operation failed to detect white blood cells
(WBCs). In contrast, the LF retained neutrophils that tightly
adhered to the polyester fibers (Figure 1).
Leukocyte counts were obtained at defined time points
during the operation (Figure 2). Time kinetics showed that
during surgical intervention without CPB (group I), total
WBC counts (Figure 2, A) slightly increased by 18% at time
point B, 12% at time point C, and 5% at time point D versus
time point A (13.5  103/L; range, 10.3-16.1  103/L).
In animals operated on with CPB (group II), the total WBC
counts further increased over time, with a maximum at time
point D (time point B, 28%; time point C, 39%; time point
D, 76% vs time point A (9.4  103/L; range, 4.8-13.2 
103/L). The use of the standard LF LG6 (group III) failed
to limit the CPB-associated increase in WBC counts (time
point B, 10%; time point C, 21%; time point D, 79% vs
time point A, 6.5 103/L; range, 4.3-8.6 103/L). Thus
no significant differences in WBC counts could be detected
between groups II and III. In contrast, when animals were
operated on with CPB and LIM (group IV), WBC counts
were found to be decreased versus time point A (13.1 
103/L; range, 6.9-17.2  103/L) during the entire obser-
vation period (time point B, 43%; time point C, 24%;
time point D, 29%). The difference in time kinetics be-
Figure 1. Microscopic evaluation of polyester fibers derived from
a standard LF (A) and from the LIM (B) after termination of CPB.
Cells were characterized by means of May-Gruenwald/Giemsa
staining.
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tween groups II and IV was statistically significant (P 
.024, MANOVA). However, significant differences were
not found between groups for each single time interval.
Overall, similar effects were found for neutrophil counts
(Figure 2, B). The neutrophil mean values and ranges at
time point A were 4.6  103/L (3.5-5.3  103/L) for
group I, 4.6  103/L (1.4-7.4  103/L) for group II, 2.4
 103/L (1.4-4.3  103/L) for group III, and 6.6 
103/L (1.8-15.0  103/L) for group IV. In group I
neutrophil counts were found to be increased at time point
B and subsequently decreased (time point B, 85%; time
point C, 59%; time point D, 45% vs time point A). In group
II counts increased over time to reach maximum values at
time point D (time point B, 67%; time point C, 76%; time
point D, 112% vs time point A). The LF (group III) limited
the increase in neutrophil counts at time points B (12%) and
C (36%) but not at time point D (112%) versus time point
A. When animals were operated on with CPB and LIM
(group IV), neutrophil counts were 32% (time point B),
12% (time point C), and29% (time point D) versus time
point A. However, differences between groups were not
statistically significant either in time kinetics or at each time
interval.
The peripheral blood lymphocyte mean values and
ranges at time point A were 8.6  103/L (6.4-10.1 
103/L) for group I, 4.6  103/L (1.3-6.8  103/L) for
group II, 3.8  103/L (2.8-5.3  103/L) for group III,
and 7.7 103/L (5.0-10.1 103/L) for group IV. As for
lymphocytes (Fig 2, C), decreased counts were found in
group I (time point B, 16%; time point C, 11%; and
time point D,14%) versus time point A. In the CPB group
increased counts were detected at time points C and D (time
point B, 15%; time point C, 11%; and time point D, 36%
vs time point A). CPB and LG6 (group III) failed to prevent
the increase in lymphocyte counts (time point B, 21%;
time point C, 16%; and time point D, 67% vs time point A).
When animals were operated on with CPB and LIM (group
IV), lymphocyte counts were reduced (time point B,48%;
time point C,25%; and time point D,19% vs time point
A). The differences in lymphocyte counts over time (time
kinetics) between groups III and IV (LG6 and LIM) but not
between the other groups were statistically significant (P 
Figure 2. Time kinetics (time points A, B, C, and D) of leukocyte
counts: A, WBCs; B, neutrophils; C, peripheral blood lymphocytes
(PBL). Data of different groups (control group without CPB, CPB
group, LF group, and LIM group) are shown. Preoperative values
(time point A) were defined as 100%. Relative data are shown as
the mean from 5 independent experiments. The WBC mean  SD
values at time point A were 13.5  2.1  103/L for group I, 9.4
 5.0  103/L for group II, 6.5  1.9  103/L for group III, and
13.1  8.5  103/L for group IV. The neutrophil mean values 
SD at time point A were 4.6  0.7  103/L for group I, 4.6  2.9
 103/L for group II, 2.4  1.1  103/L for group III, and 6.6 
5.5  103/L for group IV. The PBL mean values  SD at time
point A were 8.6  1.4  103/L for group I, 4.6  2.3  103/L
for group II, 3.8  0.9  103/L for group III, and 7.7  2.4 
103/L for group IV. The difference in time kinetics of WBC counts
between groups II and IV but not between the other groups was
statistically significant (*P  .024, MANOVA). No significant
differences between groups were found for neutrophils
(MANOVA). As for PBL counts, only the comparison between
groups III and IV showed statistical difference (*P  .016,
MANOVA). However, significant differences were not found be-
tween groups for each single time interval (Fisher exact test).
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.016, MANOVA). No statistically significant differences
were found when single time intervals were compared be-
tween groups (Fisher exact test).
Because activated neutrophils might elicit severe patho-
genic sequelae during cardiac surgery with CPB, we further
focused on the functional effects of the LIM on neutrophil
activity. First, we studied, by means of flow cytometry,
whether cardiac surgery and CPB with or without the LIM
might impair the ability of neutrophils to undergo sponta-
neous apoptosis. In all blood samples obtained from groups
I to IV (Table 1), spontaneous neutrophil apoptosis (annexin
V/PI) was detected at time point A (range, 49.4%-
91.2%). In groups I to III the percentage of annexin V/PI
cells decreased by up to 80% over time (time points B-D).
In contrast, in group IV the percentage of annexin V/PI
neutrophils increased (n  2), for example, from 77.3% at
time point A to 89.5% (time point B) and remained around
baseline level (time point C, 75.2%; time point D, 76.6%).
Moreover, in 2 animals of group IV but in none of groups
I to III, late apoptosis (annexin V/PI; 11.7% and 3.72%)
at time point C and necrosis (annexin V/PI; 9.0% and
9.3% at time point D) were found. Statistical differences
between groups were not found, except between groups II
and IV at time points B and C (P  .05, Fisher exact test).
To find out whether the LIM might prevent the secretion
of proinflammatory cytokines, TNF- levels were serially
determined in porcine blood samples by means of ELISA.
Whereas TNF- levels increased over time in groups I to III
(200% at time point D), no enhanced levels were found in
group IV (time point A, 57.4  9.0 pg/mL; time point B,
43.6  3.5 pg/mL; time point C, 43.2  3.2 pg/mL; time
point D, 46.4  7.8 pg/mL). In group III (LF) extremely
high TNF- values in 2 of 5 animals were detected (mean
values 800%). Differences between groups II and IV and
between groups III and IV at time points B, C, and D, but
not at time point A, were statistically significant (P  .05).
Mean  SD values are shown in Figure 3 for all groups.
As a further functional parameter, neutrophil IL-8–di-
rected chemotactic migration was evaluated. Over time
(time points A-D), the numbers of transmigrating neutro-
phils increased in groups II (P  .036, MANOVA) and III
(P  .044, MANOVA) compared with in group I. Maxi-
mum values were found in group II at time point D (451 
250; range, 165-850). In group IV neutrophil transmigration
was totally abrogated at time points B, C, and D (P  .05
vs group II but not group III, Fisher exact test). Figure 4
shows absolute and mean data (n 5, groups I-IV) obtained
with neutrophils isolated at time points A to D.
As tissue damage parameters, systemic CK and myocar-
dium-specific isoenzyme CK-MB levels were determined
by means of ELISA. As shown in Figure 5, CK and CK-MB
levels increased 1.3-fold and 1.4-fold in group I, respec-
tively, whereas both markers increased 1.9-fold over time
(time point D) when animals were operated on with CPB
(group II). In groups III and IV the CPB-associated increase
of CK and CK-MB was limited (group III, 1.5-fold and
1.3-fold; group IV, 1.2-fold and 1.5-fold). Differences be-
tween groups II and IV at time points B and C but not A and
D were statistically significant (P  .05; Fisher exact test).
TABLE 1. Percentage of neutrophils undergoing early ap-
optosis
Time point
A B C D
Group I 49.4 15.6 29.7 19.6
64.7 32.8 34.7 25.3
55.4 25.9 49.6 56.2
79.8 37.7 48.2 33.7
72.1 35.6 27.9 37.1
Group II 68.5 18.5 17.9 58.9
59.8 49.6 42.2 44.8
36.9 16.9 24.9 42.3
86.3 33.3 39 38.5
54.6 12.1 32.1 39.9
Group III 91.2 21.9 52.2 67.1
66.8 28.5 44.8 45.7
50.1 14.9 32.4 62.7
72.8 22.6 29.3 35.3
69.3 34 52.7 48.1
Group IV 77.3 89.5 75.2 76.6
65.9 64.7 58.3 54.8
52.6 69 79.3 68.4
68.1 62.2 52.4 57.2
82 79.4 57.4 54.6
Blood samples were obtained immediately before onset of CPB (time point
A), 5 minutes before opening of the aortic crossclamp (time point B), 15
minutes after opening of the aortic crossclamp (time point C), and 10
minutes after weaning from CPB (time point D). Statistical differences
between groups were not found, except between groups II and IV at time
points B and C (P  .05, Fisher exact test).
Figure 3. Serum levels of TNF- in each group depicted as time
kinetics (time points A-D). Data are shown as the mean (n 5)
SD. *P < .05 for group IV (LIM) versus groups II and III (CPB and
LF).
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Discussion
Highly activated neutrophils might cause severe pathogenic
sequelae related to cardiac surgery with CPB. Therefore the
inhibition of neutrophil activity is an important goal to
achieve. Here we have shown that the LIM, but not leuko-
cyte filtration, overall prevented neutrophil activity during
cardiac surgery in a porcine model. The LIM was found to
manipulate leukocyte functions within the blood stream.
The theoretic approach for the development of the LIM
was the in vitro finding that neutrophils that attach to FasL
(CD95L or APO-1L) expressing epithelial cells through Fas
(CD95) lose their cell-to-cell contacts within minutes and
fail to transmigrate the epithelial barrier.10 This unexpected
finding was found to be independent from Fas/FasL-medi-
ated apoptosis, which is known to play an important phys-
iologic role in the regulation of innate immune responses.11
FasL belongs to the TNF family and is the ligand of Fas that
is expressed on activated leukocytes and on other tissue
cells, especially in immune-privileged sites.12 The interac-
tion of FasL with Fas triggers apoptosis signaling and cell
death. Deregulated Fas/FasL-dependent mechanisms are in-
volved in many autoimmune and inflammatory diseases,
such as Hashimoto thyroiditis,13 hepatitis,14 or myasthenia
gravis.15 Therapeutically, soluble Fas has been used to
prevent hepatitis B in mice14 or for the treatment of sys-
temic lupus erythematosus.16 Moreover, monoclonal anti-
bodies against CD95 (anti-Fas) have been used to induce
apoptosis in tumor cells17 and to kill HIV-infected cells.18
Figure 4. Time kinetics of neutrophil IL-8 – directed chemotaxis, as determined in transwell chambers. Neutrophils
were isolated from blood obtained at time points A to D from different groups (without CPB, with CPB alone, CPB
plus LF, and CPB plus LIM). Data are depicted as the absolute numbers of transmigrated cells that were counted
in the lower chamber. The results of each measurement are shown as open circles, and the mean values are
shown as bars (n 5 in each group). Differences between groups II and IV but not between groups III and IV were
statistically significant at time points B, C, and D (P < .05, Fisher exact test).
Figure 5. Serum levels of CK (A) and CK-MB (B) are depicted as
time kinetics for each group. Data are shown as the means (n 
5)  SD. *P < .05 for the LIM group versus the CPB group (Fisher
exact test).
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Unfortunately, local induction of apoptosis or administra-
tion of anti-Fas antibodies, for example in the lung, have
been reported to induce severe inflammatory and fibrotic
disorders.19,20 In contrast to these previous approaches, we
here report on anti-Fas-mediated effects that are limited to
an extracorporeal device. Experiments with radioactive-
labeled antibodies showed that binding to the LIM surface is
stable, even under adequate flow conditions (not shown).
Thus the LIM allows the inactivation of floating neutrophils
after a short transient contact with the Fas-stimulating poly-
ester fiber surface without affecting other tissues by means
of apoptosis-induced inflammation. Inactivation occurs
within minutes, and inactive neutrophils immediately can be
recognized and ingested by macrophages.21
Experimentally, apoptosis normally is not detectable be-
fore 4 hours after Fas/FasL stimulation,10 and thus the
functional neutrophil inhibition observed in our in vivo
study is likely to occur independent of apoptosis. However,
we compared ex vivo the percentage of neutrophils that
undergo spontaneous apoptosis among groups 4 hours after
neutrophil isolation. These experiments revealed that the
surgical procedures (groups I-III) decreased the percentage
of spontaneous early apoptotic neutrophils compared with
neutrophils isolated before the operation. In 2 of 5 animals,
the LIM prevented the decrease in apoptotic neutrophils,
suggesting that the LIM induces early apoptosis through
CD95 stimulation. Impaired apoptosis, delayed apoptosis,
or both is known to be associated with proinflammatory
diseases, such as Kawasaki disease22 and systemic inflam-
matory response syndrome.23 Accordingly, in cardiac sur-
gery delayed apoptosis of neutrophils has been associated
with inflammatory disorders,24 and thus CD95 stimulation
by the LIM might be an adequate tool to prevent these
disorders. However, preliminary annexin V/PI data obtained
with whole blood immediately after collection currently
does not provide evidence for LIM-mediated rapid induc-
tion of apoptosis (unpublished data). Therefore we suggest
that the observed Fas-related inhibition of neutrophil activ-
ity precedes apoptosis, a phenomenon that has been de-
scribed recently.10
Further studies now have to evaluate in detail the fate of
leukocytes that have passed the LIM in a quantitative man-
ner. In addition, further investigations into the molecular
mechanisms are needed. We speculate that Fas signaling–
related phenotypic cellular changes25 might lead to a rapid
clearance of inactive-preapoptotic neutrophils by phago-
cytes.21 This would explain the reduced leukocyte numbers
observed in the LIM group but not in the LF group, although
we found trapped neutrophils within the filter mesh of the
LF but almost no leukocytes within the LIM. The increase
of WBCs and neutrophils over time in groups I and II but
also in the LF group might be explained by the intraopera-
tive release of neutrophil precursors from the bone marrow.7
The LF probably reduced leukocyte counts only transiently
during the early phase of CPB, which is in accordance with
findings from clinical studies.26 Moreover, the lymphocyte
population was found to be significantly reduced in the LIM
versus LF group, which also might be due to CD95-medi-
ated inactivation.10 It has been reported that surgical trauma
and CPB modulate leukocyte counts, and this function
might contribute to CPB-related immunosuppression and
increased incidence of postoperative infectious complica-
tions.27 Our data indicate that the LIM stabilizes the lym-
phocyte population at least regarding the lymphocyte counts
at the end of the operation. Moreover, mitogen-induced
lymphocyte proliferation was found at any time point in
either group, indicating that the LIM does not impair func-
tional activity of lymphocytes (not shown).
In contrast, the LIM significantly limited the levels of the
proinflammatory cytokine TNF-, which is known to con-
tribute to the development of systemic inflammatory re-
sponse syndrome28 and epithelial barrier dysfunction.29 The
LIM therefore might be an important tool to prevent TNF-
–related pathogenesis without pharmacologic interven-
tion30 in cardiac surgery but also in other clinical settings,
such as transplantation, trauma, or sepsis.28 Preliminary
results in a similar experimental setting showed that in
addition to TNF-, CPB-mediated increases in IL-6 and
IL-8 levels are also prevented by the LIM (unpublished
data).
In addition, endothelial leakage and extracellular matrix
destruction might result from neutrophil adhesion and trans-
endothelial migration.3,4 In our transwell chamber assay, we
found a significant CPB-mediated increase of IL-8–directed
neutrophil transmigration activity over time. Surprisingly,
neutrophils in the LIM group lost their ability to transmi-
grate in this model. This finding, in conjunction with the
failure to detect adherent neutrophils within the LIM, con-
firms recently published in vitro data showing neutrophil
inactivation after short contact with FasL-expressing epithe-
lial cells.10 The underlying signaling and biochemical path-
ways downstream from Fas that lead to the rapid functional
loss are thus far unknown.
Overall, evidence was found that the LIM protected from
CPB-associated pathogenicity because CK and CK-MB val-
ues were reduced compared with those with CPB alone.
Although similar findings were observed in the LF group, in
a previous clinical trial with high-risk patients and an LF,
we found rather increased values for CK and CK-MB in the
filter group (unpublished data) in conjunction with signifi-
cantly increased PMNE values.9 Unfortunately, we were not
able to measure porcine PMNE because of the lack of
commercially available porcine PMNE in ELISA.
The reason for the rather negative effects of the LF
observed in this study are unclear. However, we suppose
that neutrophils that are trapped within the filter mesh are
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still active and secrete proinflammatory cytokines that in
turn stimulate unappreciated immune functions. The finding
that the LF, in spite of the failure to reduce overall leukocyte
counts, reduced CK and CK-MB levels on the other hand
might be due to the LF feature of trapping a significant
number of activated neutrophils, thus preventing neutrophil
adhesion to the endothelium and subsequent tissue damage.
It is surprising that the LIM also limits CK and CK-MB
increase without trapping neutrophils, underlining the effi-
cient CD95-mediated neutrophil inactivation within the
LIM.
Ongoing studies in the same experimental setup revealed
that the LIM elicits positive effects on the postoperative
cardiac function (unpublished). However, we were not able
to show whether the LIM has beneficial effects on pulmo-
nary, renal, and liver function because in our model CPB-
mediated decrease in organ function could not be observed.
On the cerebral level, the LIM did not prevent CPB-medi-
ated leakage of the porcine blood-brain barrier, as detected
with Evan’s blue injection and postoperative histologic and
photometric evaluation. However, the relevance of this find-
ing is unclear because cerebral edema could not be detected
by means of magnetic resonance tomography (data not
shown).
In conclusion, in our porcine model the LIM proved to be
an effective tool to functionally inhibit leukocyte activation
and thus to limit pathogenic sequelae related to cardiac
surgery with CPB. The LIM allows the inactivation of
neutrophils through Fas stimulation without affecting other
organs by apoptosis-mediated inflammation.22,23 Further
studies ought to be conducted to evaluate postoperative
benefits and the efficacy of the LIM in clinical studies.
We appreciate the excellent technical assistance of Mrs Vera
Beinrucker and Mrs Alexandra Best. For statistical analyses, we
are grateful to Dr Sonia Area de Leao Sitals.
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